These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29460719)

  • 1. Characterization of Cotton Rat (
    Green MG; Petroff N; La Perle KMD; Niewiesk S
    Comp Med; 2018 Feb; 68(1):31-40. PubMed ID: 29460719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
    Castilow EM; Meyerholz DK; Varga SM
    J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus.
    Sawada A; Nakayama T
    Microbiol Immunol; 2016 Apr; 60(4):234-42. PubMed ID: 26865035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease.
    Shaw CA; Galarneau JR; Bowenkamp KE; Swanson KA; Palmer GA; Palladino G; Markovits JE; Valiante NM; Dormitzer PR; Otten GR
    Vaccine; 2013 Jan; 31(2):306-12. PubMed ID: 23153444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus).
    Grieves JL; Yin Z; Durbin RK; Durbin JE
    Comp Med; 2015 Aug; 65(4):315-26. PubMed ID: 26310461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease.
    Muralidharan A; Larocque L; Russell M; Creskey M; Li C; Chen W; Van Domselaar G; Cao J; Cyr T; Rosu-Myles M; Wang L; Li X
    Sci Rep; 2019 Aug; 9(1):11638. PubMed ID: 31406266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
    Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys.
    Sawada A; Yunomae K; Nakayama T
    Microbiol Immunol; 2018 Feb; 62(2):132-136. PubMed ID: 29194753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
    Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
    Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.
    Boukhvalova MS; Yim KC; Blanco J
    Antivir Chem Chemother; 2018; 26():2040206618770518. PubMed ID: 29768937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary function analysis in cotton rats after respiratory syncytial virus infection.
    Martinez ME; Harder OE; Rosas LE; Joseph L; Davis IC; Niewiesk S
    PLoS One; 2020; 15(8):e0237404. PubMed ID: 32776985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.
    Boukhvalova MS; Sotomayor TB; Point RC; Pletneva LM; Prince GA; Blanco JC
    J Interferon Cytokine Res; 2010 Apr; 30(4):229-42. PubMed ID: 20038196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.